Bakhu Holdings, Corp. Share Price

Equities

BKUH

US0575862083

Healthcare Facilities & Services

Market Closed - OTC Markets 20:17:51 26/04/2024 BST 5-day change 1st Jan Change
0.25 USD 0.00% Intraday chart for Bakhu Holdings, Corp. 0.00% +150.00%
Sales 2022 - Sales 2023 - Capitalization 298M 23.77B
Net income 2022 -20M -1.59B Net income 2023 -10M -797M EV / Sales 2022 -
Net Debt 2022 6.36M 507M Net Debt 2023 6.74M 537M EV / Sales 2023 -
P/E ratio 2022
-15.8 x
P/E ratio 2023
-28.9 x
Employees 2
Yield 2022 *
-
Yield 2023
-
Free-Float 34.7%
More Fundamentals * Assessed data
Dynamic Chart
3 months+150.00%
6 months-75.00%
Current year+150.00%
More quotes
1 week
0.25
Extreme 0.25
0.25
1 month
0.25
Extreme 0.25
0.25
Current year
0.11
Extreme 0.11
0.25
1 year
0.01
Extreme 0.005
1.11
3 years
0.00
Extreme 0.0011
7.99
5 years
0.00
Extreme 0.0011
14.00
10 years
0.00
Extreme 0.0011
188.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO 51 05/12/21
Chief Tech/Sci/R&D Officer 55 02/08/12
Director/Board Member 29 02/08/12
Members of the board TitleAgeSince
Director of Finance/CFO 51 05/12/21
Chairman 63 02-26
Chief Tech/Sci/R&D Officer 55 02/08/12
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, April 26, 2024 at 08:17 pm

More quotes
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.
More about the company